Takeda maps out a discovery alliance aimed at breaking through the safety and efficacy boundaries that limit the first-gen gene therapies
MIT headliner Harvey Lodish and Jiahai Shi in Hong Kong leant some of their work in red blood cells to help found Rubius, a Flagship …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
